Farther Finance Advisors LLC Has $1.72 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Farther Finance Advisors LLC raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.4% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 3,289 shares of the medical equipment provider’s stock after purchasing an additional 389 shares during the quarter. Farther Finance Advisors LLC’s holdings in Intuitive Surgical were worth $1,717,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of ISRG. EverSource Wealth Advisors LLC grew its position in shares of Intuitive Surgical by 16.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,210 shares of the medical equipment provider’s stock valued at $632,000 after purchasing an additional 170 shares during the period. Sequoia Financial Advisors LLC grew its position in shares of Intuitive Surgical by 12.4% in the 4th quarter. Sequoia Financial Advisors LLC now owns 8,560 shares of the medical equipment provider’s stock valued at $4,468,000 after purchasing an additional 942 shares during the period. PFG Advisors grew its position in shares of Intuitive Surgical by 0.8% in the 4th quarter. PFG Advisors now owns 5,837 shares of the medical equipment provider’s stock valued at $3,047,000 after purchasing an additional 49 shares during the period. Wealth High Governance Capital Ltda acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at approximately $6,484,000. Finally, Moors & Cabot Inc. grew its position in shares of Intuitive Surgical by 8.4% in the 4th quarter. Moors & Cabot Inc. now owns 1,256 shares of the medical equipment provider’s stock valued at $656,000 after purchasing an additional 97 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of the stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This represents a 60.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 22,209 shares of company stock worth $11,928,127. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Trading Down 4.1 %

Intuitive Surgical stock opened at $476.78 on Friday. The company has a market capitalization of $169.82 billion, a PE ratio of 74.38, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a 50-day moving average price of $568.47 and a two-hundred day moving average price of $531.22.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on ISRG shares. Truist Financial boosted their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Jefferies Financial Group boosted their price objective on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Leerink Partners boosted their target price on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, CICC Research initiated coverage on Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.